Insulin-like growth factor binding protein-3 (IGFBP-3): a biomarker of coronary artery disease induced myocardial ischaemia
Our discovery approach has translated IGFBP-3 as a potential biomarker to identify significant CAD/ischaemia in patients who do not meet diagnostic thresholds for MI.
Authors
- Philip D Adamson (ORCID: https://orcid.org/0000-0002-6177-956X)
- K Jina
- Jan Powell (ORCID: https://orcid.org/0000-0001-5250-8883)
- Jacqui A Lee
- Martin Than (ORCID: https://orcid.org/0000-0001-9399-5227)
- Louise N. Paton (ORCID: https://orcid.org/0000-0002-7055-5170)
- Pedro López‐Ayala (ORCID: https://orcid.org/0000-0002-7787-0640)
- Mark Richards (ORCID: https://orcid.org/0000-0002-2023-8177)
- W. Frank Peacock (ORCID: https://orcid.org/0000-0002-2730-6742)
- Chris Frampton (ORCID: https://orcid.org/0000-0003-3109-4348)
- Richard W. Troughton (ORCID: https://orcid.org/0000-0001-7484-4036)
- Luca Koechlin (ORCID: https://orcid.org/0000-0002-2929-8600)
- John W. Pickering (ORCID: https://orcid.org/0000-0001-9475-0344)
- Jasper Boeddinghaus (ORCID: https://orcid.org/0000-0003-4404-4956)
- Sara D Raudsepp
- Christian Mueller (ORCID: https://orcid.org/0000-0001-9544-5421)
- Jessika Wise
- Sally Aldous
- James L. Januzzi (ORCID: https://orcid.org/0000-0002-8338-1798)
- Noah Erceg
Institutions
- Harvard University (US)
- Baylor College of Medicine (US)
- Ben Taub Hospital (US)
- University Hospital of Basel (CH)
- Christchurch Hospital (NZ)
- Massachusetts General Hospital (US)
- Hospital Base (CL)
- New Zealand Brain Research Institute (NZ)
- Baim Institute for Clinical Research (US)
- Christchurch Clinical Studies Trust (NZ)
- MedTech CoRE (NZ)
- University of Kansas Medical Center (US)
- University of Otago (NZ)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/ehjopen/oeaf028
- Citations
- 5
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 6.94